Want to join the conversation?
Steve Scala of Cowen asks about Sutent long-term outlook, given the competition from immuno-oncology agents. $PFE President Albert Bourla said that the company is confident in its position in the Sutent and Inlyta space. $PFE is studying Inlyta plus other PD-1 inhibitors aggressively to achieve better results than monotherapy in RCC second line.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.